Gene · 4588
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. | J Immunother Cancer | 2023 | 36927528 | PubTator, text mining | PubMed |
| Acute cervicitis resembling gastric-type mucinous adenocarcinoma that was definitively diagnosed by cervical conization: A case report. | Radiol Case Rep | 2023 | 36923387 | PubTator, text mining | PubMed |
| Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes. | BMC Gastroenterol | 2023 | 36906562 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? | Int J Mol Sci | 2023 | 36901856 | PubTator, text mining | PubMed |
| The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer. | Cancers (Basel) | 2023 | 36900282 | PubTator, text mining | PubMed |
| Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan. | J Gastroenterol | 2023 | 36855000 | PubTator, text mining | PubMed |
| View from the Biological Property: Insight into the Functional Diversity and Complexity of the Gut Mucus. | Int J Mol Sci | 2023 | 36835646 | PubTator, text mining | PubMed |
| Complexification of In Vitro Models of Intestinal Barriers, A True Challenge for a More Accurate Alternative Approach. | Int J Mol Sci | 2023 | 36835003 | PubTator, text mining | PubMed |
| MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients. | Cancers (Basel) | 2023 | 36831343 | PubTator, text mining | PubMed |
| Lymph node metastasis after endoscopic submucosal dissection of a superficial esophageal adenocarcinoma arising from the ectopic gastric mucosa of the cervical esophagus: A case report. | DEN Open | 2023 | 36825033 | PubTator, text mining | PubMed |
| Knowledge of mucin immunostaining status of "nuclear inverse polarity papillary lesions lacking myoepithelial cells" may prevent unnecessary breast surgery: experience of two cases. | J Int Med Res | 2023 | 36823991 | PubTator, text mining | PubMed |
| Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities. | Arch Pathol Lab Med | 2023 | 36821179 | PubTator, text mining | PubMed |
| Pancreatic colloid adenocarcinoma arising from intraductal papillary mucinous neoplasm: Radiologic-pathologic correlation with cinematic rendering. | Acta Radiol Open | 2023 | 36817179 | PubTator, text mining | PubMed |
| Clinicopathological Features and the Prevalence of Oxyntic Gland Neoplasm: A Single-center Retrospective Study. | Intern Med | 2023 | 36792200 | PubTator, text mining | PubMed |
| Primary duodenal carcinoma suspected to arise from ectopic gastric mucosa: a case report. | Surg Case Rep | 2023 | 36781821 | PubTator, text mining | PubMed |
| Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer. | Aging (Albany NY) | 2023 | 36779847 | PubTator, text mining | PubMed |
| Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines. | Diagnostics (Basel) | 2023 | 36766560 | PubTator, text mining | PubMed |
| Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program. | Cancers (Basel) | 2023 | 36765865 | PubTator, text mining | PubMed |
| An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. | Cancer Inform | 2023 | 36762284 | PubTator, text mining | PubMed |
| An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection. | Nat Mater | 2023 | 36759564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4588/papers?page=20